Pregnancy-related issues in women with systemic lupus erythematosus

International Journal of Rheumatic Diseases

Volumn 18, Issue 2, 2015, Pages 172-181

  Singh, Abha G ^a   Chowdhary, Vaidehi R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Miscellaneous topics; Systemic lupus erythematous

Indexed keywords

AZATHIOPRINE; BELIMUMAB; CORTICOSTEROID; CYCLOSPORIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; LEFLUNOMIDE; MEPREDNISONE; PREDNISONE; RITUXIMAB; TACROLIMUS;

ADVERSE OUTCOME; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ASIAN; CONCEPTION; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE EXACERBATION; DRUG SAFETY; FEMALE; FETUS DISEASE; FETUS OUTCOME; HIGH RISK PREGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS; MATERNAL DISEASE; NEONATAL LUPUS; NEWBORN DISEASE; OBSTETRIC PATIENT; PATIENT COUNSELING; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREPREGNANCY CARE; PRIORITY JOURNAL; RISK FACTOR; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; COMPLICATION; FETAL DISEASES; GESTATIONAL AGE; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RISK ASSESSMENT; SURVIVAL RATE;

DISEASE PROGRESSION; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84927909487     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12524     Document Type: Article

References (47)

1. Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 6, 468-76.
2. Petri M (2002) Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16, 847-58.
3. Lateef A, Petri M (2012) Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol 8, 710-8.
4. Clowse ME, Jamison M, Myers E, James AH (2008) A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199(2), 127.e1-e6.
5. Lateef A, Petri M (2013) Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 27, 435-47.
6. Yasmeen S, Wilkins EE, Field NT, Sheikh RA, Gilbert WM (2001) Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 10 (2), 91-6.
7. Clark CA, Spitzer KA, Laskin CA (2005) Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 32, 1709-12.
8. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5, 2060-8.
9. Vinet E, Labrecque J, Pineau CA et al. (2012) A population-based assessment of live births in women with systemic lupus erythematosus. Ann Rheum Dis 71, 557-9.
10. Barnabe C, Faris PD, Quan H (2011) Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol 2011, 345727.
11. Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J (2011) Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 40 (1), 27-41.
12. Buyon JP, Winchester RJ, Slade SG et al. (1993) Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 36, 1263-73.
13. Buyon JP, Kim MY, Copel JA, Friedman DM (2001) Anti-Ro/SSA antibodies and congenital heart block: necessary but not sufficient. Arthritis Rheum 44, 1723-7.
14. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK (2002) Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol 39 (1), 130-7.
15. Buyon JP, Hiebert R, Copel J et al. (1998) Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31, 1658-66.
16. Izmirly PM, Kim MY, Llanos C et al. (2010) Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 69, 1827-30.
17. Clowse ME, Magder LS, Witter F, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52, 514-21.
18. Al Arfaj AS, Khalil N (2010) Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus 19, 1665-73.
19. Clowse ME, Wallace DJ, Weisman M, James A, Criscione-Schreiber LG, Pisetsky DS (2013) Predictors of preterm birth in patients with mild systemic lupus erythematosus. Ann Rheum Dis 72, 1536-9.
20. McNeil HP, Chesterman CN, Krilis SA (1991) Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49, 193-280.
21. Yazdany J, Trupin L, Kaiser R et al. (2011) Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Arthritis Care Res 63, 358-65.
22. Schwarz EB, Manzi S (2008) Risk of unintended pregnancy among women with systemic lupus erythematosus. Arthritis Rheum 59, 863-6.
23. Kwok LW, Tam LS, Zhu T, Leung YY, Li E (2011) Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 20, 829-36.
24. Culwell KR, Curtis KM, del Carmen Cravioto M (2009) Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review. Obstet Gynecol 114 (2 Pt 1), 341-53.
25. Baer AN, Witter FR, Petri M (2011) Lupus and pregnancy. Obstet Gynecol Surv 66, 639-53.
26. US FDA (2012) Mycophenolate REMS. Accessed on August 21, 2014. http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM321261.pdf
27. Clowse ME, Magder L, Witter F, Petri M (2006) Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54, 3640-7.
28. Levy RA, Vilela VS, Cataldo MJ et al. (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10, 401-4.
29. Nielsen GL, Sorensen HT, Larsen H, Pedersen L (2001) Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 322, 266-70.
30. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME (2006) Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 40, 824-9.
31. Ostensen M, Khamashta M, Lockshin M et al. (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (3), 209.
32. Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR (1996) A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14, 131-6.
33. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80, 614-20.
34. Meng K, Hu X, Peng X, Zhang Z (2014) Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis. J Matern Fetal Neonatal Med doi:10.3109/14767058.2014.913130.
35. Andreoli L, Fredi M, Nalli C et al. (2012) Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun 38 (2-3), J197-208.
36. Empson M, Lassere M, Craig JC, Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99 (1), 135-44.
37. Stojan G, Baer AN (2012) Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Exp Rev Clin Immunol 8, 439-53.
38. Carvalheiras G, Vita P, Marta S et al. (2010) Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin Rev Allergy Immunol 38 (2-3), 302-6.
39. Petri M, Howard D, Repke J (1991) Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 34 (12), 1538-45.
40. Petri M (1997) Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am 23 (1), 1-13.
41. Gladman DD, Tandon A, Ibanez D, Urowitz MB (2010) The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 37, 754-8.
42. Imbasciati E, Tincani A, Gregorini G et al. (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 24, 519-25.
43. Hayslett JP (1991) Maternal and fetal complications in pregnant women with systemic lupus erythematosus. Am J Kidney Dis 17, 123-6.
44. Saavedra MA, Cruz-Reyes C, Vera-Lastra O et al. (2012) Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol 31, 813-9.
45. Chen CY, Chen YH, Lin HC, Chen SF, Lin HC (2010) Increased risk of adverse pregnancy outcomes for hospitalisation of women with lupus during pregnancy: a nationwide population-based study. Clin Exp Rheumatol 28 (1), 49-55.
46. Ideguchi H, Ohno S, Uehara T, Ishigatsubo Y (2013) Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clin Rev Allergy Immunol 44 (1), 57-64.
47. Ko HS, Ahn HY, Jang DG et al. (2011) Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int J Med Sci 8, 577-83.